日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exploiting collateral sensitivity in the evolution of resistance to tyrosine kinase inhibitors in soft tissue sarcomas.

利用软组织肉瘤对酪氨酸激酶抑制剂产生耐药性的伴随敏感性

Elms Mark L, Jenks Andrew D, Chowdhury Avirup, Krasny Lukas, Chadha Madhumeeta, Low Kaan, Harrison Peter T, Kerrison William G, Jones Robin L, Huang Paul H

Characterisation of a Novel Cell Line (ICR-SS-1) Established from a Patient-Derived Xenograft of Synovial Sarcoma

对源自滑膜肉瘤患者异种移植瘤的新型细胞系 (ICR-SS-1) 进行表征

Kerrison, William G J; Ning, Jian; Krasny, Lukas; Arthur, Amani; Guljar, Nafia; Elms, Mark L; Swain, Amanda; Jones, Robin L; Thway, Khin; Huang, Paul H

The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib

肉瘤中酪氨酸激酶抑制剂的现状:帕唑帕尼之外的治疗选择

Wilding, Christopher P; Elms, Mark L; Judson, Ian; Tan, Aik-Choon; Jones, Robin L; Huang, Paul H